drug-eluting stent(s), dualantiplatelet therapy, high bleeding risk, high thrombotic risk, zotarolimus-eluting stent(s)
dx.doi.org/10.1016/j.jacc.2014.11.053, hdl.handle.net/1765/85158
Journal of the American College of Cardiology
Erasmus MC: University Medical Center Rotterdam

Valgimigli, M, Patialiakas, A, Thury, A, McFadden, E, Colangelo, S, Campo, G, … Briguori, C. (2015). Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. Journal of the American College of Cardiology, 65(8), 805–815. doi:10.1016/j.jacc.2014.11.053